Sanofi revamps beauty; Bastien is out

Drake, Alicia
November 1996
WWD: Women's Wear Daily;11/1/1996, Vol. 172 Issue 85, p12
Trade Publication
Reports on the decentralization within the Sanofi Beaute division. Resignation of managing director Vincent Bastien; Change in name of division; Appointed brand managing directors.


Related Articles

  • Shored-up Sanofi heads into the black. Born, Pete // WWD: Women's Wear Daily;6/30/1995, Vol. 169 Issue 126, p4 

    Reports on the financial recovery of Sanofi Beaute Inc. Anticipation of break-even performance in 1995; Strategies implemented by the company to boost growth; Comments by Vincent Bastien, managing director of Sanofi's worldwide organization in Paris, France.

  • Sanofi's bold moves for L'Air du Temps. Larson, Soren // WWD: Women's Wear Daily;10/8/1993, Vol. 166 Issue 69, p4 

    Reports on Sanofi Beute Incorporated's marketing strategy for the L'Air du Temps women's scent. United States distribution of Nina Ricci's 1948 fragrance; Benefits of the strategy; Projected gains from the product; Estimates of advertising and promotional costs; Replacement of the L'Air du...

  • Sanofi Beaute sales up in '95.  // WWD: Women's Wear Daily;3/21/1996, Vol. 171 Issue 56, p2 

    Presents statistics on the rise in sales in the department of cosmetics and fragrances at Sanofi Beaute SA store in New York.

  • Sanofi adds 3 at the top. Raper, Sarah // WWD: Women's Wear Daily;7/2/1993, Vol. 166 Issue 2, p4 

    Reports on Sanofi Beaute SA's addition of top key personnel to ease the integration of Yves Saint Laurent Parfums SA into the cosmetic company. Reorganization following the acquisition; Appointment of Pierre Berlancourt as managing director for operations; Jean-Luc Bertrand as financial director...

  • Expanded use for Dynabac.  // Drug Topics;3/16/98, Vol. 142 Issue 6, p8 

    Focuses on the approval for expanded coverage within certain indications given to Dynabac (dirithromycin tables) manufactured by Sanofi. Details on the use of drug for treatment of acute bacterial exacerbations of chronic bronchitis; Information on the clearance of the drug for shorter course...

  • Sales down 5% at Sanofi Beaute.  // WWD: Women's Wear Daily;11/14/1995, Vol. 170 Issue 91, p16 

    Reports on the financial performance of Sanofi Beaute for the first nine months of 1995. Sales and earnings; Tightening of distribution; Strong performance of Yves Saint Laurent's Opium Pour Homme.

  • Sanofi says it's still mulling sale of Oscar' fragrance.  // WWD: Women's Wear Daily;9/12/1994, Vol. 168 Issue 51, p2 

    Reports on Sanofi SA's evaluation of whether it will sell its Oscar de la Renta fragrance business. Other fragrance brands put on the block for sale; Oscar de la Renta's possible acquisition offer for the fragrance; Rumors regarding Procter & Gamble Co.'s interest in acquiring the Oscar de la...

  • Lipofactor draws a following. Diamond, Kerry // WWD: Women's Wear Daily;8/27/1999, Vol. 178 Issue 41, p6 

    Features Lipofactor, a cellulite lotion from Sanofi Beaute Inc. Retail price of the cellulite lotion; Information about the product; Estimated amount in sales revenues to be generated by Lipofactor during its first year of circulating within the cosmetics market.

  • Sanofi's new R&D site.  // Chemical Week;10/25/1995, Vol. 157 Issue 15, p41 

    Reports that Sanofi has opened a research and development center in Malvern, Pennsylvania.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics